SCHEMBL17791099

SCHEMBL17791099

Cc1ccc(Oc2cc(Cl)cc(Cl)c2C(=O)Nc2cccc(S(N)(=O)=O)c2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17791098 0.90 — —
SCHEMBL16408372 0.87 — —
SCHEMBL29918757 0.83 — —
SCHEMBL16397884 0.83 — —
SCHEMBL16408375 0.83 — —
SCHEMBL16398460 0.83 — —
SCHEMBL29919009 0.83 — —
SCHEMBL14372394 0.80 CA1 (0.61) —
SCHEMBL16398456 0.80 — —
SCHEMBL17791103 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160152561-A1 SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2016-06-02 — — US disclosed
Send feedback